VIce President and Head of Global Medical Governance
Bayer Healthcare Pharmaceuticals
Neurology
Dr. Pamela A. Cyrus works in the field of Neurology. She went to medical school at Joan C. Edwards School of Medicine. Pamela Cyrus is a published doctor as well. She has 11 publications published. The latest was: Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.
Publications
- Time to symptom relief for uncomplicated urinary tract infection treated with extended-release ciprofloxacin: a prospective, open-label, uncontrolled primary care study.
- Efficacy of metrifonate in improving the psychiatric and behavioral disturbances of patients with Alzheimer''s disease.
- Metrifonate therapy in Alzheimer''s disease: a pooled analysis of four randomized, double-blind, placebo-controlled trials.
- Metrifonate enhances the ability of Alzheimer''s disease patients to initiate, organize, and execute instrumental and basic activities of daily living.
- Randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety and tolerability of metrifonate in patients with probable Alzheimer disease. The...
- Metrifonate treatment of AD: influence of APOE genotype.
- The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients. Metrifonate Study Group.
- Efficacy and safety of a loading-dose regimen versus a no-loading-dose regimen of metrifonate in the symptomatic treatment of Alzheimer's disease: a randomized, double...
- Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.
- Metrifonate treatment of the cognitive deficits of Alzheimer's disease. Metrifonate Study Group.
Schools
Doctors Specialties
Accepted Insurances
Education
-
Boston University Medical Center
-
Joan C. Edwards School of Medicine
Helpful Reviews
Give
Anonymous Review
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog